Dr. Zachary D Crees, M.D.
Claim this profileWashington University School of Medicine
Studies Plasma Cell Neoplasm
Studies Multiple Myeloma
8 reported clinical trials
15 drugs studied
Affiliated Hospitals
Clinical Trials Zachary D Crees, M.D. is currently running
Motixafortide + G-CSF
for Multiple Myeloma
This study includes extended CD34+ profiling on the apheresis product of multiple myeloma patients undergoing standard-of-care quad-induction followed by motixafortide + G-CSF mobilization, and in addition, assesses the pharmacodynamics (PD) of motixafortide following "standard" (\~12 hours) vs "early" (\~16 hours) dosing. The investigators hypothesize that quad-induction may alter the stem cell subsets within the mobilized graft. The investigators further hypothesize that standard and early dosing strategies will result in comparable mobilization and stem cell collection rates.
Recruiting1 award Phase 16 criteria
Mosunetuzumab
for Aggressive B-Cell Lymphoma
This phase 1 pilot study examines the feasibility and safety of mosunetuzumab after autologous stem cell transplant for patients with aggressive B cell lymphomas. Mosunetuzumab is an antibody that has been engineered to attach to two target cells in the immune system: T cells that normally perform tasks like killing virus-infected cells, and cancerous B cells. Mosunetuzumab has been designed to direct these T cells to kill the cancerous B cells instead.
Recruiting2 awards Phase 1
More about Zachary D Crees, M.D.
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Zachary D Crees, M.D. has experience with
- Motixafortide
- Leukapheresis
- Natalizumab
- Flotetuzumab
- MGD006
- Donor Lymphocyte Infusion
Breakdown of trials Zachary D Crees, M.D. has run
Plasma Cell Neoplasm
Multiple Myeloma
Sickle Cell Disease
Myelodysplastic syndrome
T-Lymphoblastic Leukemia/Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Zachary D Crees, M.D. specialize in?
Zachary D Crees, M.D. focuses on Plasma Cell Neoplasm and Multiple Myeloma. In particular, much of their work with Plasma Cell Neoplasm has involved treating patients, or patients who are undergoing treatment.
Is Zachary D Crees, M.D. currently recruiting for clinical trials?
Yes, Zachary D Crees, M.D. is currently recruiting for 6 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Zachary D Crees, M.D. has studied deeply?
Yes, Zachary D Crees, M.D. has studied treatments such as Motixafortide, Leukapheresis, Natalizumab.
What is the best way to schedule an appointment with Zachary D Crees, M.D.?
Apply for one of the trials that Zachary D Crees, M.D. is conducting.
What is the office address of Zachary D Crees, M.D.?
The office of Zachary D Crees, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.